1. Jemec GB, Gniadecka M, Ulrich J. Ultrasound in dermatology. Part I. High frequency ultrasound. European journal of dermatology: EJD. 2000 Aug; 10(6): 492-7.
2. Singer AJ, Clark RA. Cutaneous wound healing. New England journal of medicine. 1999 Sep 2; 341(10): 738-46.
3. Leaper DJ. Silver dressings: their role in wound management. International wound journal. 2006 Dec 1; 3(4): 282-94.
4. Wright JB, Lam K, Hansen D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. American journal of infection control. 1999 Aug 31; 27(4): 344-50.
5. Logsetty S, Heimbach DM. Modern techniques for wound coverage of the thermally injured upper extremity. Hand clinics. 2000 May; 16(2): 205-14.
6. Fraser JF, Bodman J, Sturgess R, Faoagali J, Kimble RM. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns. 2004 Feb 29; 30(1): 35-41.
7. O’Neill MA, Vine GJ, Beezer AE, Bishop AH, Hadgraft J, Labetoulle C, Walker M, Bowler PG. Antimicrobial properties of silver-containing wound dressings: a microcalorimetric study. International journal of pharmaceutics. 2003 Sep 16; 263(1): 61-8.
8. Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: a review. Journal of pharmaceutical sciences. 2008 Aug 1; 97(8): 2892-923.
9. Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing-review of the literature. Burns. 2005 Dec 31; 31(8): 944-56.
10. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns. 2000 Mar 31; 26(2): 131-8.
11. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK. Antimicrobial effects of silver nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine. 2007 Mar 31; 3(1): 95-101.
12. Ung T, Liz-Marzán LM, Mulvaney P. Controlled method for silica coating of silver colloids. Influence of coating on the rate of chemical reactions. Langmuir. 1998 Jul 7; 14(14): 3740-8.
13. Brett DW. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy/wound management. 2006 Jan; 52(1): 34-41.
14. Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns. 2007 Dec 31; 33(8): 979-85.
15. White JM, Powell AM, Brady K, Russell-Jones R. Severe generalized argyria secondary to ingestion of colloidal silver protein. Clinical and experimental dermatology. 2003 May 1; 28(3): 254-6.
16. Hori K, Martin TG, Rainey P, Robertson WO. Believe it or not--silver still poisons! Veterinary and Human Toxicology. 2002 Oct; 44(5): 291-2.
17. Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB, Santamaria AB. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicological sciences. 2006 Jan 1; 89(1): 42-50.
18. Warheit DB, Borm PJ, Hennes C, Lademann J. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhalation toxicology. 2007 Jan 1; 19(8): 631-43.
19. Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, Larese FF. Nanoparticle dermal absorption and toxicity: a review of the literature. International archives of occupational and environmental health. 2009 Oct 1; 82(9): 1043-55.
20. Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plastic and reconstructive surgery. 2006 Jun 1; 117(7S): 110S-8S.
21. Lam PK, Chan ES, Ho WS, Liew CT. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. British journal of biomedical science. 2004 Jul 1; 61(3): 125.
22. Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? Journal of pharmaceutical sciences. 2010 Jan 1; 99(1): 21-50.
23. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicology letters. 2008 Jan 4; 176(1): 1-2.
24. Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, Sigg L, Behra R. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environmental science & technology. 2008 Oct 1; 42(23): 8959-64.
25. Blaser SA, Scheringer M, MacLeod M, Hungerbühler K. Estimation of cumulative aquatic exposure and risk due to silver: contribution of
nano-functionalized plastics and textiles. Science of the total environment. 2008 Feb 15; 390(2): 396-409.
26. Chang AL, Khosravi V, Egbert B. A case of argyria after colloidal silver ingestion. Journal of cutaneous pathology. 2006 Dec 1; 33(12): 809-11.
27. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, Huang L. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound repair and regeneration. 2007 Jan 1; 15(1): 94-104.
28. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns. 2004 Mar 31; 30(2): 140-7.
29. Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns. 2007 Dec 31; 33(8): 979-85.
30. Cuttle L, Naidu S, Mill J, Hoskins W, Das K, Kimble RM. A retrospective cohort study of Acticoat™ versus Silvazine™ in a paediatric population. Burns. 2007 Sep 30; 33(6): 701-7.
31. Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, Thorne PS. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 2011; 8(1): 5.
32. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 1996; 26(3): 255-60.
33. Tang J, Xi T. Status of biological evaluation on silver nanoparticles. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2008; 25(4): 958-61.
34. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, et al. Twenty eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 2008; 20(6): 575-83.
35. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 2010; 7(1): 20.
36. Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci 2011; 73(11): 1417-23.
37. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver coated dressing Acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006; 60(3): 648-52.
38. Pronk M, Wijnhoven S, Bleeker E, Heugens E, Peijnenburg W, Luttik R, et al. Nanomaterials under REACH. Nanosilver as a case study, RIVM rapport 2009.
39. Park E-J, Bae E, Yi J, et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 2010; 30: 162-8.
40. Bidgoli SA, Mahdavi M, Rezayat SM, Korani M, Amani A, Ziarati P. Toxicity assessment of nanosilver wound dressing in Wistar rat. Acta Medica Iranica. 2013 Apr 1; 51(4): 203.
41. Korani M, Rezayat SM, Gilani K, Bidgoli SA, Adeli S. Acute and subchronic dermal toxicity of nanosilver in guinea pig. Int J Nanomedicine. 2011 Jan 1; 6(1): 855-62.
42. Hafezi F, Rad HE, Naghibzadeh B, Nouhi A, Naghibzadeh G. Actinidia deliciosa (kiwifruit), a new drug for enzymatic debridement of acute burn wounds. Burns. 2010 May 31; 36(3): 352-5.
